PEN

Penumbra, Inc.

$318.95 +0.20%

Recent alerts on PEN

All signals →

News Penumbra Among Well-Insulated Companies From Ongoing Tariff Dynamics, Says Analyst

News Why Penumbra Stock Zoomed Nearly 5% Higher Today

News Penumbra CEO Adam Elsesser sells shares worth over $3 million - Investing.com

News ServisFirst Gets Axed by Champlain — a Minor Position in a Major Drawdown

News Tudor adds Warner Bros. Discovery stake, boosts SPY, trims QQQ in Q1

SEC filing PEN Announces $2B Merger with Boston Scientific, 99.7% Shareholder Approval, $5.5B Deal Value

News Penumbra GAAP EPS of $0.82 misses by $0.26, revenue of $374.8M beats by $2.76M

News Abbott is the most oversold healthcare stock as Q1 earnings roll on

Insider trade Sale by Harpreet Grewal

Insider trade Sale by Maggie Yuen (Chief Financial Officer)

News $HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--PEN, RAPT, NATH, and LSTA

News Boston Scientific Advises Removal Of Certain AXIOS Stents After Deployment Issues Surface

News Notable healthcare headlines for the week: Eli Lilly, UnitedHealth, and Boston Scientific in focus

News Key deals this week: Micron Technology, Worthington Steel, Boston Scientific, CrowdStrike and more

News Halper Sadeh LLC Encourages PEN, CVGW, AVO Shareholders to Contact the Firm to Discuss Their Rights

News Deal Dispatch: From $14B Medtech Buys To Vodka Bankruptcies, This Week's M&A Roundup

News Penumbra Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Penumbra, Inc. - PEN

News SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Penumbra, Inc. (NYSE: PEN)

News Global Neurovascular Devices Market Set to Grow Steadily at a CAGR of ~8% by 2032 | DelveInsight

News Shareholder Alert: The Ademi Firm investigates whether Penumbra, Inc. is obtaining a Fair Price for its Public Shareholders

News Boston Scientific Acquires Penumbra In $14.5 Billion Bet To Dominate Thrombectomy

News Boston Scientific is buying Penumbra for $14.5 billion, gaining entry to ‘fast-growing’ vascular segments

News Boston Scientific to buy Penumbra in $14.5 billion deal

News Boston Scientific Will Buy Penumbra In $14.5 Billion Medtech Deal

News Boston Scientific Buys Device Maker Penumbra for $14.5 Billion

Get push alerts for PEN

Add it to your watchlist in the app and receive every signal the moment it fires.

Download for iOS

Download for iOS